Study on DNA patterns in brain, thyroid, and uterine cancers
Part of Cancer clinical trials.
This trial uses a special test called the methylome to study DNA changes in three types of solid tumors: gliomas (brain tumors), malignant thyroid neoplasms, and endometrial carcinomas (uterine cancer). It aims to better understand these cancers to improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of one of these cancers: glioma, malignant thyroid cancer, or endometrial cancer.
- The lab needs at least 3 slices of your tumor sample, each 10 micrometers thick, from a stored paraffin block.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new immunotherapy treatment for advanced or recurrent endometrial cancer. It uses your tumor's genetic features to see if the treatment might work better for you.
This study looks at patient tissue from needle biopsies to see if DNA “methylation” patterns can help diagnose and guide treatment for thyroid nodules. You might benefit by helping improve how these nodules are evaluated, using information from your biopsy sample and medical data.
This study looks at a molecular test (DNA methylation pattern) using samples taken during fine-needle aspiration (FNA) of thyroid nodules. It aims to help identify which thyroid nodules that looked “unclear” after the first test may be cancer.
This trial is collecting tissue and blood samples from people with rare gynecological cancers, such as unusual ovarian tumors, uterine sarcomas, or vulvar cancer. The goal is to use advanced lab tests (called multi-omics) to learn more about these cancers and improve treatment.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study collects and analyzes molecular (cell/DNA-level) information from endocrine tumors or pre-cancer conditions. It may help doctors better understand these tumors and improve diagnosis and treatment planning when you need surgery or a biopsy.
Hear when a new Solid Tumor Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.